Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
ENTA | ENANTA PHARMACEUTICALS INC | Rottinghaus Scott T. | Chief Medical Officer | Aug 08, 2024 | Option Exercise | $12.73 | 1,466 | 18,662 | 18,784 | Aug 09, 2024, 05:24 PM | |
ENTA | ENANTA PHARMACEUTICALS INC | Rottinghaus Scott T. | Chief Medical Officer | Aug 08, 2023 | Option Exercise | $17.23 | 1,467 | 25,276 | 25,533 | Aug 09, 2024, 05:24 PM | |
ENTA | ENANTA PHARMACEUTICALS INC | Rottinghaus Scott T. | Chief Medical Officer | Jul 11, 2024 | Sale | $15.07 | 4,299 | 64,786 | 23,988 | Jul 15, 2024, 05:29 PM | |
ENTA | ENANTA PHARMACEUTICALS INC | Rottinghaus Scott T. | Chief Medical Officer | Jul 12, 2024 | Sale | $15.04 | 2,271 | 34,156 | 21,717 | Jul 15, 2024, 05:29 PM | |
ENTA | ENANTA PHARMACEUTICALS INC | Rottinghaus Scott T. | Chief Medical Officer | Jul 15, 2024 | Option Exercise | $8.99 | 5,375 | 48,321 | 27,092 | Jul 15, 2024, 05:29 PM | |
ENTA | ENANTA PHARMACEUTICALS INC | Rottinghaus Scott T. | Chief Medical Officer | Jul 15, 2024 | Sale | $17.08 | 5,375 | 91,805 | 21,717 | Jul 15, 2024, 05:29 PM | |
ENTA | ENANTA PHARMACEUTICALS INC | Rottinghaus Scott T. | Chief Medical Officer | Feb 12, 2024 | Option Exercise | $12.41 | 755 | 9,370 | 28,287 | Feb 14, 2024, 08:15 PM | |
ENTA | ENANTA PHARMACEUTICALS INC | Rottinghaus Scott T. | Sr. VP & CMO | Dec 05, 2023 | Sale | $9.63 | 534 | 5,142 | 26,466 | Dec 06, 2023, 08:24 PM |